Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research.
Tag: Prostate Cancer
The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy
Abstract Background Magnetic resonance imaging (MRI)-targeted prostate biopsy (MRI-biopsy) detects high-Grade Group (GG) prostate cancers not identified by systematic biopsy (S-biopsy). However, questions have been raised whether cancers detected by MRI-biopsy and S-biopsy, grade-for-grade, are of equivalent oncologic risk. The authors evaluated the relative oncologic risk of GG diagnosed by S-biopsy and MRI-biopsy. Methods This… Continue reading The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy
The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy
MRI-biopsy detects high-Grade Group (GG) prostate cancers not identified by systematic biopsy . The authors evaluated relative oncologic risk of cancers diagnosed by MRI and S-Biopsy in a retrospective analysis of patients at Memorial Sloan Kettering Cancer Center . If grade was discordant between biopsies, then the risk was intermediate between grades. For example, the… Continue reading The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy
Scientists discover potential biomarkers linked to metastatic prostate cancer in Black men
Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments for… Continue reading Scientists discover potential biomarkers linked to metastatic prostate cancer in Black men
Researchers identify biomarkers that may detect risk of advance prostate cancer in Black men
Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments for Black men with these diseases. Credit: City of Hope Scientists at City of Hope, one of the largest cancer research and treatment organizations in… Continue reading Researchers identify biomarkers that may detect risk of advance prostate cancer in Black men
New approach to target a deadly form of prostate cancer
Study uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of cancer .
Research into use of diabetes medication for treatment of metastatic prostate cancer
Patients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high . Until now, the precise mechanism behind the spread of tumor has not been fully explained . But an international research team has succeeded in decoding the underlying cellular signal… Continue reading Research into use of diabetes medication for treatment of metastatic prostate cancer
[ASAP] Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer
[ASAP] Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer
FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers
FDA approved enzalutamide (Xtandi) combined with talazoparib (Talzenna) for metastatic castration-resistant prostate cancer with alterations in any of 12 DNA repair genes . The drug combination was more effective than the standard treatment in a large clinical trial